🌿 2025 IDA｜EU–Middle East × Southeast Asia Medical Business Forums Highlights

GrowTrend Biomedical Showcases the World’s Smallest Bilevel PAP Device and AccuLiner Focused Ultrasound System
On November 10, 2025, GrowTrend Biomedical Co., Ltd. was invited to participate in the EU–Middle East Medical Business Forum in Taipei and the Southeast Asia Medical Business Forum at the Hsinchu Biomedical Science Park.
These events, organized under the initiative of the Industrial Development Administration (IDA) and the Industrial Technology Research Institute (ITRI), aimed to support medical device companies in developing their own global expansion strategies.
The two forums gathered experts and partners from Europe, the Middle East, and Southeast Asia, focusing on market trends, cross-border collaboration, and international business opportunities.
Through in-depth discussions and 1-on-1 business matchmaking sessions, the events fostered meaningful partnerships and opened new avenues for cooperation.

GrowTrend showcased two flagship innovations:
🌬️ The world’s smallest portable Bilevel PAP micro device —
independently developed by GrowTrend, recognized by international experts for its breakthrough respiratory technology and strong clinical potential.
💎 AccuLiner Focused Ultrasound System —
delivering precise aesthetic energy for non-invasive lifting and contouring, demonstrating the company’s excellence in intelligent aesthetic integration.
These international engagements reinforced GrowTrend’s leadership in Intelligent Respiratory Care × Precision Aesthetic Energy,
creating new momentum for expansion across Europe, the Middle East, and Southeast Asia.

GrowTrend Biomedical will continue to advance innovations in Respiratory Science and Aesthetic Medicine, extending respiratory technologies into wellness and beauty applications.

By integrating clinical evidence with the vision of “Beautiful Living,” GrowTrend is shaping a new industry value that harmonizes health, aesthetics, and intelligent living—moving confidently toward the global market.